Cargando…
Mannan-Binding Lectin in Diabetic Kidney Disease: The Impact of Mouse Genetics in a Type 1 Diabetes Model
Background. Mannan-binding lectin (MBL) is involved in the development of diabetic nephropathy. MBL is a part of the innate immune system where it can activate the complement system. Serum MBL level predicts later renal impairment in diabetes patients. Direct involvement of MBL in the development of...
Autores principales: | Østergaard, Jakob Appel, Bjerre, Mette, RamachandraRao, Satish Posettihalli, Sharma, Kumar, Nyengaard, Jens Randel, Hansen, Troels Krarup, Thiel, Steffen, Flyvbjerg, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356895/ https://www.ncbi.nlm.nih.gov/pubmed/22645604 http://dx.doi.org/10.1155/2012/678381 |
Ejemplares similares
-
Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin
por: Axelgaard, Esben, et al.
Publicado: (2017) -
Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes
por: Dørflinger, Gry Høst, et al.
Publicado: (2017) -
Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes
por: Axelgaard, Esben, et al.
Publicado: (2017) -
Increased Autoreactivity of the Complement-Activating Molecule Mannan-Binding Lectin in a Type 1 Diabetes Model
por: Østergaard, Jakob Appel, et al.
Publicado: (2016) -
The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetes
por: Østergaard, Jakob Appel, et al.
Publicado: (2021)